IHI vs. ARKG
IHI (iShares U.S. Medical Devices ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both Health & Biotech Equities funds. IHI is passively managed, while ARKG is actively managed. Over the past 10 years, IHI returned 8.43%/yr vs 9.10%/yr for ARKG. A 0.57 correlation means they provide meaningful diversification when combined. IHI charges 0.38%/yr vs 0.75%/yr for ARKG.
Performance
IHI vs. ARKG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IHI achieves a -18.54% return, which is significantly lower than ARKG's 37.63% return. Over the past 10 years, IHI has underperformed ARKG with an annualized return of 8.43%, while ARKG has yielded a comparatively higher 9.10% annualized return.
IHI
- 1D
- -3.24%
- 1M
- 4.36%
- 6M
- -18.12%
- YTD
- -18.54%
- 1Y
- -15.41%
- 3Y*
- -3.16%
- 5Y*
- -3.26%
- 10Y*
- 8.43%
ARKG
- 1D
- -0.55%
- 1M
- 13.78%
- 6M
- 25.30%
- YTD
- 37.63%
- 1Y
- 62.80%
- 3Y*
- 1.83%
- 5Y*
- -13.51%
- 10Y*
- 9.10%
IHI vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IHI iShares U.S. Medical Devices ETF | -18.54% | 6.88% | 8.62% | 3.24% | -19.80% | 21.03% | 24.17% | 32.75% | 15.45% | 30.81% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 37.63% | 23.04% | -28.24% | 16.22% | -53.90% | -33.92% | 180.40% | 44.00% | -1.26% | 46.61% |
Correlation
The correlation between IHI and ARKG is 0.40, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.40 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.47 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.55 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.57 |
Correlation (All Time) Calculated using the full available price history since Oct 31, 2014 | 0.57 |
The correlation between IHI and ARKG shifts across timeframes, from 0.40 (1 year) to 0.57 (all time), reflecting how their relationship changes across market environments.
IHI vs. ARKG - Sectors Allocation Comparison
Sectors
IHI
ARKG
Healthcare
Technology
Industrials
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Real Estate
-
-
Utilities
-
-
Healthcare
IHI
ARKG
Technology
IHI
ARKG
Industrials
IHI
ARKG
-
Basic Materials
IHI
-
ARKG
-
Communication Services
IHI
-
ARKG
-
Consumer Cyclical
IHI
-
ARKG
-
Consumer Defensive
IHI
-
ARKG
-
Energy
IHI
-
ARKG
-
Financial Services
IHI
-
ARKG
Real Estate
IHI
-
ARKG
-
Utilities
IHI
-
ARKG
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IHI vs. ARKG — Risk / Return Rank
IHI
ARKG
IHI vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Medical Devices ETF (IHI) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IHI | ARKG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.27 | ||
| Sortino ratioReturn per unit of downside risk | -3.22 | ||
| Omega ratioGain probability vs. loss probability | 0.88 | 1.25 | -0.37 |
| Calmar ratioReturn relative to maximum drawdown | -0.59 | 2.29 | -2.89 |
| Martin ratioReturn relative to average drawdown | -1.22 | 5.45 | -6.68 |
Loading charts...
Drawdowns
IHI vs. ARKG - Drawdown Comparison
The maximum IHI drawdown since its inception was -49.65%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for IHI and ARKG.
Loading charts...
Drawdown Indicators
| IHI | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -49.65% | -83.59% | +33.94% |
Max Drawdown (1Y)Largest decline over 1 year | -26.11% | -27.51% | +1.40% |
Max Drawdown (3Y)Largest decline over 3 years | -26.64% | -51.96% | +25.32% |
Max Drawdown (5Y)Largest decline over 5 years | -33.12% | -79.26% | +46.14% |
Max Drawdown (10Y)Largest decline over 10 years | -33.25% | -83.59% | +50.34% |
Current DrawdownCurrent decline from peak | -23.08% | -64.33% | +41.25% |
Average DrawdownAverage peak-to-trough decline | -8.41% | -36.17% | +27.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.63% | 11.55% | +1.08% |
Volatility
IHI vs. ARKG - Volatility Comparison
The current volatility for iShares U.S. Medical Devices ETF (IHI) is 10.17%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 12.42%. This indicates that IHI experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IHI | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.17% | 12.42% | -2.25% |
Volatility (6M)Calculated over the trailing 6-month period | 16.15% | 31.43% | -15.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.55% | 42.89% | -23.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.48% | 46.10% | -26.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.98% | 41.39% | -21.41% |
IHI vs. ARKG - Expense Ratio Comparison
IHI has a 0.38% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Dividends
IHI vs. ARKG - Dividend Comparison
IHI's dividend yield for the trailing twelve months is around 0.48%, while ARKG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% | 0.00% | 0.00% |
IHI iShares U.S. Medical Devices ETF | 0.48% | 0.34% | 0.46% | 0.53% | 0.45% | 0.25% | 0.25% | 0.33% | 0.26% | 0.37% | 0.55% | 1.28% |
Frequently Asked Questions
IHI and ARKG have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (12.42%) compared to IHI (10.17%). In terms of maximum drawdown, IHI dropped -49.65% vs ARKG's -83.59%.
On 10-year performance, ARKG leads with 9.10% vs 8.43% for IHI. On fees, IHI is cheaper at 0.38% per year. On volatility, IHI has been the lower-risk option at 10.17%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, ARKG has performed better with a 9.10% return vs 8.43%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IHI is cheaper with a 0.38% expense ratio, compared with 0.75% for ARKG.
IHI has the higher dividend yield at 0.48%, compared with 0.00% for ARKG.
They also come from different issuers: iShares and ARK. Their fees differ too: 0.38% for IHI and 0.75% for ARKG.
ARKG currently has the higher Sharpe Ratio (1.47 vs -0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IHI and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer